Heron Therapeutics, Inc. (HRTX)
USD 1.9
(4.4%)
USD 1.9
(4.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 127.04 Million | 107.67 Million | 86.34 Million | 88.63 Million | 145.96 Million | 77.47 Million |
| Cost of Revenue | 65.1 Million | 54.87 Million | 46.02 Million | 36.18 Million | 61.61 Million | 27.51 Million |
| Gross Profit | 61.93 Million | 52.79 Million | 40.32 Million | 52.44 Million | 84.34 Million | 49.96 Million |
| Operating Expenses | 172.55 Million | 227.45 Million | 258.15 Million | 280.61 Million | 295.04 Million | 233.89 Million |
| Selling, General and Administrative Expenses | 116.65 Million | 119.95 Million | 127.33 Million | 106.07 Million | 127.66 Million | 93.86 Million |
| Research and Development Expenses | 55.89 Million | 107.5 Million | 130.82 Million | 174.53 Million | 167.38 Million | 140.03 Million |
| Other Expenses | - | -7.36 Million | -2.85 Million | 885 Thousand | 5.94 Million | 5.09 Million |
| Cost and Expenses | 237.65 Million | 282.33 Million | 304.17 Million | 316.8 Million | 356.66 Million | 261.41 Million |
| Operating Income | -110.61 Million | -174.65 Million | -217.82 Million | -228.16 Million | -210.69 Million | -183.93 Million |
| Interest Expense | 3.86 Million | 2.47 Million | 2.41 Million | 1.9 Million | 1.47 Million | 2.67 Million |
| Income Tax Expense | - | -47.5 Million | -3.02 Million | -2.84 Million | 1.87 Million | 7.76 Million |
| Earnings before Tax | -110.55 Million | -182.02 Million | -220.68 Million | -227.27 Million | -204.74 Million | -178.84 Million |
| Net Income | -110.55 Million | -134.51 Million | -217.66 Million | -224.43 Million | -204.74 Million | -178.84 Million |
| Earnings Per Share Basic | -0.80 | -1.24 | -2.21 | -2.47 | -2.50 | -2.44 |
| Earnings Per Share Diluted | -0.80 | -1.24 | -2.21 | -2.47 | -2.50 | -2.44 |
| Weighted Average Shares Outstanding | 138.13 Million | 108.87 Million | 98.47 Million | 90.77 Million | 81.77 Million | 73.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 138.13 Million | 108.87 Million | 98.47 Million | 90.77 Million | 81.77 Million | 73.19 Million |
| Gross Margin | 0.49 | 0.49 | 0.47 | 0.59 | 0.58 | 0.64 |
| EBIT Margin | -0.82 | -1.62 | -2.52 | -2.57 | -1.43 | -2.37 |
| Profit Margin | -0.87 | -1.25 | -2.52 | -2.53 | -1.40 | -2.31 |
| EBITDA | -103.79 Million | -176.66 Million | -215.25 Million | -222.53 Million | -201.23 Million | -174.65 Million |
| Earnings Before Tax Margin | -0.87 | -1.62 | -2.52 | -2.57 | -1.44 | -2.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 36.02 Million | 34.67 Million | 127.04 Million | 34.23 Million | 31.43 Million | 31.76 Million |
| Cost of Revenue | 10.51 Million | 8.44 Million | 65.1 Million | 9.88 Million | 18.2 Million | 20.15 Million |
| Gross Profit | 25.5 Million | 26.22 Million | 61.93 Million | 24.34 Million | 13.22 Million | 11.6 Million |
| Operating Expenses | 31.95 Million | 31.02 Million | 172.55 Million | 34.56 Million | 38.15 Million | 54 Million |
| Selling, General and Administrative Expenses | 27.51 Million | 26.41 Million | - | 23.61 Million | 24.59 Million | 36.43 Million |
| Research and Development Expenses | 4.43 Million | 4.6 Million | - | 10.95 Million | 13.55 Million | 17.57 Million |
| Other Expenses | -2.79 Million | 1.63 Million | 560 Thousand | -560 Thousand | -79 Thousand | 344 Thousand |
| Cost and Expenses | 42.46 Million | 39.46 Million | 237.65 Million | 44.45 Million | 56.36 Million | 74.16 Million |
| Operating Income | -6.44 Million | -4.79 Million | -110.61 Million | -10.22 Million | -24.92 Million | -42.4 Million |
| Interest Expense | - | - | 3.86 Million | 2.16 Million | 563 Thousand | 563 Thousand |
| Income Tax Expense | - | 645.72 Thousand | 2.73 Million | 295 Thousand | 766.58 Thousand | 616.91 Thousand |
| Earnings before Tax | -9.23 Million | -3.16 Million | -110.55 Million | -10.72 Million | -25 Million | -42.05 Million |
| Net Income | -9.23 Million | -3.16 Million | -110.55 Million | -10.72 Million | -25 Million | -42.05 Million |
| Earnings Per Share Basic | -0.06 | -0.02 | - | -0.07 | -0.17 | -0.35 |
| Earnings Per Share Diluted | -0.06 | -0.02 | - | -0.07 | -0.17 | -0.35 |
| Weighted Average Shares Outstanding | 152.3 Million | 151.19 Million | 138.13 Million | 150.28 Million | 144.99 Million | 119.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 152.3 Million | 151.19 Million | 138.13 Million | 150.28 Million | 144.99 Million | 119.71 Million |
| Gross Margin | 0.71 | 0.76 | 0.49 | 0.71 | 0.42 | 0.37 |
| EBIT Margin | -0.16 | -0.12 | - | -0.28 | -0.77 | -1.31 |
| Profit Margin | -0.26 | -0.09 | -0.87 | -0.31 | -0.80 | -1.32 |
| EBITDA | -5.8 Million | -4.1 Million | - | -9.5 Million | -24.2 Million | -41.66 Million |
| Earnings Before Tax Margin | -0.18 | -0.14 | -0.87 | -0.30 | -0.79 | -1.34 |
4987
NHMAF
SNPHF
9938
AUB
BE